FDA Approves First Cell-Based Gene Therapy for Adult Patients with Multiple Myeloma ...Middle East

SILVER SPRING, Md., March 27, 2021 /PRNewswire/ -- The U.S. Food and Drug Administration approved Abecma (idecabtagene vicleucel), a cell-based gene therapy to treat adult patients with multiple myeloma who have not responded to, or whose disease has returned after, at least four prior...

Hence then, the article about fda approves first cell based gene therapy for adult patients with multiple myeloma was published today ( Saturday 27/03/2021 - 06:00 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves First Cell-Based Gene Therapy for Adult Patients with Multiple Myeloma )

Also on site :

• Trump’s letter to Norway proves it: he’s lost his mind over the Nobel Peace Prize
• Michael Kors Outlet Has a 'Roomy' Shoulder Bag That Oozes Style on Sale for Just $76
• Trump refuses ‘to think purely of peace’